Fortress Biotech (NASDAQ:FBIO – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Several other research firms have also recently weighed in on FBIO. Alliance Global Partners initiated coverage on shares of Fortress Biotech in a research report […]
Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 3,200 shares, an increase of 33.3% from the April 30th total of 2,400 shares. Based on an average trading volume of 10,800 shares, […]
Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 3,200 shares, an increase of 33.3% from the April 30th total of 2,400 shares. Based on an average daily trading volume, of 10,800 shares, the days-to-cover […]
StockNews.com upgraded shares of Fortress Biotech (NASDAQ:FBIO – Free Report) from a sell rating to a hold rating in a report issued on Thursday. Several other brokerages also recently issued reports on FBIO. Alliance Global Partners initiated coverage on shares of Fortress Biotech in a research note on Tuesday, March 19th. They issued a buy […]
Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald acquired 10,000 shares of the stock in a transaction dated Thursday, May 16th. The shares were bought at an average price of $1.76 per share, for a total transaction of $17,600.00. Following the transaction, the chief executive officer now owns 2,873,905 shares […]